Brown, Lisle/Cummings’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.1K | Hold |
475
| – | – | ﹤0.01% | 472 |
|
|
2025
Q1 | $13.5K | Hold |
475
| – | – | ﹤0.01% | 456 |
|
|
2024
Q4 | $19.8K | Sell |
475
-1,160
| -71% | -$48.2K | 0.01% | 422 |
|
|
2024
Q3 | $109K | Buy |
1,635
+100
| +7% | +$6.68K | 0.03% | 255 |
|
|
2024
Q2 | $182K | Hold |
1,535
| – | – | 0.06% | 209 |
|
|
2024
Q1 | $164K | Hold |
1,535
| – | – | 0.06% | 209 |
|
|
2023
Q4 | $153K | Hold |
1,535
| – | – | 0.06% | 208 |
|
|
2023
Q3 | $159K | Hold |
1,535
| – | – | 0.07% | 198 |
|
|
2023
Q2 | $187K | Hold |
1,535
| – | – | 0.08% | 186 |
|
|
2023
Q1 | $236K | Buy |
1,535
+1,000
| +187% | +$154K | 0.12% | 159 |
|
|
2022
Q4 | $96.1K | Hold |
535
| – | – | 0.05% | 212 |
|
|
2022
Q3 | $63.3K | Buy |
535
+150
| +39% | +$17.7K | 0.04% | 237 |
|
|
2022
Q2 | $55K | Hold |
385
| – | – | 0.03% | 252 |
|
|
2022
Q1 | $66.3K | Hold |
385
| – | – | 0.03% | 241 |
|
|
2021
Q4 | $97.8K | Buy |
+385
| New | +$97.8K | 0.05% | 209 |
|